Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Zepbound copycats remain online despite FDA ban
Tags Pharmaceuticals Novo Nordisk A/S Retail industry
From CNBC.com News
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Tags Healthy Returns Social issues Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Economy Investment strategy Government and politics
From CNBC.com News
Novo Nordisk shares fall 5.5% after latest trial results for its next-generation weight loss drug
Tags Breaking News: Markets Breaking News: Europe Novo Nordisk A/S
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Business News LILLY DRN Breaking News: Business
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Breaking News: Business LILLY DRN Business News
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags Structure Therapeutics Inc Zealand Pharma A/S Social issues
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Pharmaceuticals Biotechnology Novo Nordisk A/S
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Pharmaceuticals Health care industry Novo Nordisk A/S
From CNBC.com News
Cramer's Lightning Round: Sunoco is a buy
Tags Markets Vistra Corp S&P 500
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Health & Science Science Biotech and Pharmaceuticals
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags World economy Deere & Co LILLY DRN
From CNBC.com News
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Tags Merck & Co Inc Government and politics Breaking News: Business
From CNBC.com News
Hims & Hers faces scrutiny from lawmakers over 'misleading' Super Bowl ad
Tags Internet Novo Nordisk A/S Health care industry
From CNBC.com News
Eli Lilly to release late-stage data on next-generation weight loss drug retatrutide in 2025, earlier than expected
Tags Biotech and Pharmaceuticals Science Health & Science
From CNBC.com News
Novo Nordisk CEO says he's confident about Wegovy supply, next-generation weight loss drugs
Tags LILLY DRN Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk posts net profit beat as Wegovy sales jump 107% in fourth quarter
Tags Business Europe Economy Business News
From CNBC.com News
Healthy Returns: Why people quit weight loss, diabetes drugs within one year
Tags Healthy Returns LILLY DRN Social issues
From CNBC.com News
Jim Cramer's week ahead: Earnings from Amazon, Alphabet, Eli Lilly, Palantir
Tags Merck & Co Inc Mad Money Palantir Technologies Inc
From CNBC.com News
FDA approves Novo Nordisk’s diabetes drug Ozempic for chronic kidney disease, expanding its use
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
World's largest luxury group LVMH posts better than feared full-year sales
Tags Retail LVMH Moet Hennessy Louis Vuitton SE Business
From CNBC.com News
Food-as-medicine startups hope Kennedy, if confirmed as HHS secretary, will boost their businesses
Tags Social issues CVS Health Corp Nutrition
From CNBC.com News
Novo Nordisk shares pop 10% on early-stage weight loss drug trial results
Tags Pharmaceuticals Biotech and Pharmaceuticals Breaking News: Europe
From CNBC.com News
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Tags Healthy Returns Johnson & Johnson Social issues
From CNBC.com News
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags Breaking News: Davos Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Waystar Holding Corp Illumina Inc JPMorgan Chase & Co
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Novo Nordisk A/S Biotechnology Pharmaceuticals
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Novo Nordisk A/S Health care industry Biotech and Pharmaceuticals
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Labor economy Business Zillow Group Inc
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Biotech and Pharmaceuticals Health & Science Companies
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.